Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Nonandrogenic Anabolic Hormones Predict Risk of Frailty: European Male Ageing Study Prospective Data

Open access
Swiecicka, Agnieszka, Lunt, Mark, Ahern, Tomás, O’Neill, Terence W, Bartfai, György, Casanueva, Felipe F, Forti, Gianni, Giwercman, Aleksander, Han, Thang S, Lean, Michael E J, Pendleton, Neil, Punab, Margus, Slowikowska-Hilczer, Jolanta, Vanderschueren, Dirk, Huhtaniemi, Ilpo T, Wu, Frederick C W, Rutter, Martin K, for the EMAS Study Group · 2017 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Low levels of nonandrogenic anabolic hormones have been linked with frailty, but evidence is conflicting and prospective data are largely lacking. Objective: To determine associations between nonandrogenic anabolic hormones and prospective changes in frailty status. Design/Setting: A 4.3-year prospective observational study of community-dwelling men participating in the European Male Ageing Study. Participants: Men (n = 3369) aged 40 to 79 years from eight European centers. Main Outcome Measures: Frailty status was determined using frailty phenotype (FP; n = 2114) and frailty index (FI; n = 2444). Analysis: Regression models assessed relationships between baseline levels of insulinlike growth factor 1 (IGF-1), its binding protein 3 (IGFBP-3), dehydroepiandrosterone sulfate (DHEA-S), 25-hydroxyvitamin D (25OHD), and parathyroid hormone (PTH), with changes in frailty status (worsening or improving frailty). Results: The risk of worsening FP and FI decreased with 1 standard deviation higher IGF-1, IGFBP-3, and 25OHD in models adjusted for age, body mass index, center, and baseline frailty [IGF-1: odds ratio (OR) for worsening FP, 0.82 (0.73, 0.93), percentage change in FI, -3.7% (-6.0, -1.5); IGFBP-3: 0.84 (0.75, 0.95), -4.2% (-6.4, -2.0); 25OHD: 0.84 (0.75, 0.95); -4.4%, (-6.7, -2.0)]. Relationships between IGF-1 and FI were attenuated after adjusting for IGFBP-3. Higher DHEA-S was associated with a lower risk of worsening FP only in men >70 years old [OR, 0.57 (0.35, 0.92)]. PTH was unrelated to change in frailty status. Conclusions: These longitudinal data confirm the associations between nonandrogenic anabolic hormones and the changes in frailty status. Interventional studies are needed to establish causality and determine therapeutic implications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2017-00090

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 2

  1. Warrington, 1996, The Camden Memory Tests: Topographical Recognition Memory Test
  2. Uiterwijk, 2001, Wechsler Adult Intelligence Scale III—Nederlandstalige Bewerking (WAIS-III-NL/V)

Cited by

See all 23

Metadata

Authors
Swiecicka, A., Lunt, M., Ahern, T., O’Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., Giwercman, A., Han, T. S., Lean, M. E. J., Pendleton, N., Punab, M., Slowikowska-Hilczer, J., Vanderschueren, D., Huhtaniemi, I. T., Wu, F. C. W., Rutter, M. K., & for the EMAS Study Group
Affiliations
  • Andrology Research Unit, Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9WL, United Kingdom
  • Manchester Academic Health Science Centre (GB)
  • Department of Obstetrics, Gynecology and Andrology, Albert Szent-György Medical University, H6725 Szeged, Hungary
  • Complejo Hospitalario Universitario de Santiago (ES)
  • University of Florence (IT)
  • Lund University (SE)
  • Royal Holloway University of London (GB)
  • University of Glasgow (GB)
  • University of Manchester (GB)
  • Tartu University Hospital (EE)
  • Department of Andrology and Reproductive Endocrinology, Medical University of Lodz, 90-419 Lodz, Poland
  • KU Leuven (BE)
  • University of Turku (FI)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2017-05-09
Volume
102
Issue
8
Pages
2798-2806
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2612314571
Cited by
23
References
38
Citations by year
2026: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 6 · 2018: 5 · 2017: 1
FWCI
2.81
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion, other-oa)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • Lirias (submittedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • GlaxoSmithKline
  • National Institute for Health and Care Research
  • Novo Nordisk
  • Versus Arthritis
  • Mereo BioPharma
  • Manchester Biomedical Research Centre
  • Medical Research Council (MR/K025252/1)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Keywords
frailty, insulin-like growth factor I, IGFBP-3, dehydroepiandrosterone sulfate, 25-hydroxyvitamin D, parathyroid hormone, frailty index, Fried frailty phenotype, men, aging, community-dwelling older men, vitamin D, sex steroids
MeSH terms
Adult, Aged, Aging, Humans, Insulin-Like Growth Factor I, Longitudinal Studies, Male, Middle Aged, Parathyroid Hormone, Prospective Studies, Vitamin D, Odds Ratio, Frail Elderly, Risk Assessment, Insulin-Like Growth Factor Binding Protein 3, Dehydroepiandrosterone Sulfate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nonandrogenic Anabolic Hormones Predict Risk of Frailty: European Male Ageing Study Prospective Data. https://app.cochat.ai/papers/10.1210/jc.2017-00090
The paper
Swiecicka, A., Lunt, M., Ahern, T., O’Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., Giwercman, A., Han, T. S., Lean, M. E. J., Pendleton, N., Punab, M., Slowikowska-Hilczer, J., Vanderschueren, D., Huhtaniemi, I. T., Wu, F. C. W., Rutter, M. K., & for the EMAS Study Group. (2017). Nonandrogenic Anabolic Hormones Predict Risk of Frailty: European Male Ageing Study Prospective Data. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2017-00090

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.